Brain Neurotherapy Bio, Inc. — Form D
Brain Neurotherapy Bio, Inc. of RESEARCH TRIANGLE PARK, NC, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-11. The offering totals $600, of which $600 was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-10-11
- Form: D
- Accession: 0001755511-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $600
- Amount sold: $600
- Minimum investment: $4
- Investors: 1
- Date of first sale: 2018-10-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-323329
Issuer
- Name: Brain Neurotherapy Bio, Inc.
- CIK: 0001755511
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 20 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Phone: 510-387-4765
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Krystof Bankiewicz | Director | Research Triangle Park, NC |
| Sheila Mikhail | Director | Durham, NC |
| Krystof Bankiewicz | Executive Officer | Research Triangle Park, NC |
| Sheila Mikhail | Executive Officer | Durham, NC |
| Jude Samulski | Executive Officer | Research Triangle Park, NC |
More